Department of Immunology
Yongxin Zhang is the General Manager (CEO) for Zyxell Inc, USA. He is also doing collaborative research work with 7-Hill Pharmaceutical Inc. (Houston), Texas Heart Institute (Houston) and Southwestern Medical Center (Dallas) for hematopoietic stem cell transplantation; Halsa Pharmaceutical Inc. (Houston) and Agennex Inc. for Anti-cancer drug evaluation; Gradalis Inc. (Dallas) for the immunological evaluation of cancer vaccine; SinoStem LLC (Nanjing) for Bioreactor development and 4th Junyi University (Chongqing) for stem cell expansion. He has completed his MD from Beijing Medical College, China in the year 1983. He has received his Ph.D from Beijing Medical College, China in the year 1989. After that he has continued his postdoc training at Baylor College of Medicine during 1996-2004. Dr. Zhang has published numerous papers in reputed journals and has participated in several international conferences. He is serving as editor and reviewer for several international journals.
Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.